Family · Pharmaceutical analytical standards
Terbutaline
A selective beta-2 agonist bronchodilator developed in Sweden, patented in 1966 and in use since 1970: it relaxes the airway muscles and is used as a 'reliever' in asthma and other conditions with bronchospasm. This family brings together the active ingredient, pharmacopoeial impurities, nitrosamines and other impurities.
Did you know?Compared with adrenaline it lacks a hydroxyl group at position 4 of the ring: this lets it escape the enzyme COMT and act for longer, while its tert-butyl group makes it selective for beta-2 receptors.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
